Natco Pharma Limited
Held by 79 mutual fund schemes, ₹250.47Cr between them.
The largest single position is Tata Value Fund (Tata), which holds 0.7% of its portfolio in Natco Pharma Limited — ₹55.36Cr, or 22.1% of all the mutual fund money in this stock.
The five largest holders account for 66% of it, across 79 schemes in total.
32 of the 60 largest holdings sit in index funds, the most of any category here.
Funds holding Natco Pharma Limited
79Largest rupee position first, top 60 shown. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 74 of the 79 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Frequently asked questions
Which mutual fund holds the most Natco Pharma Limited?
By rupee value, Tata Value Fund from Tata — ₹55.36Cr, at 0.7% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Natco Pharma Limited?
DSP Nifty Smallcap250 Quality 50 Index Fund carries the largest weight at 1.5% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Natco Pharma Limited?
79 schemes, holding ₹250.47Cr between them across the 74 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Natco Pharma Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.